1 |
Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults [J]. J Circulation, 2017, 135(8): 759-771.
|
2 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
3 |
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. J Stroke, 2019, 50(12): e344-e418.
|
4 |
Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association [J]. J Stroke, 2017, 48(12): e343-e361.
|
5 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性脑梗死后出血转化诊治共识2019 [J]. 中华神经科杂志, 2019, 52(4): 252-265.
|
6 |
Whiteley WN, Slot KB, Fernandes P, et al. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies [J]. J Stroke, 2012, 43(11): 2904-2909.
|
7 |
Chang X, Zhang X, Zhang G. Different scores predict the value of hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke [J]. J Evid Based Complement Alternat Med, 2021, 2021: 2468052.
|
8 |
严晓波, 张圣, 严慎强, 等. 不同严重程度急性缺血性卒中患者静脉溶栓预后的影响因素分析 [J]. 浙江大学学报(医学版), 2015, 44(1): 54-60.
|
9 |
Ruhnau J, Schulze J, Dressel A, et al. Thrombosis, neuroinflammation, and poststroke infection: the multifaceted role of neutrophils in stroke [J]. J Immunol Res, 2017, 2017: 5140679.
|
10 |
Jin R, Liu L, Zhang S, et al. Role of inflammation and its mediators in acute ischemic stroke [J]. J Cardiovasc Transl Res, 2013, 6(5): 834-851.
|
11 |
Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans [J]. J Cereb Blood Flow Metab, 2014, 34(2): 185-199.
|
12 |
Inzitari D, Giusti B, Nencini P, et al. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death [J]. J Stroke, 2013, 44(10): 2901-2903.
|
13 |
Wang C, Zhang Q, Ji M, et al. Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis [J]. J BMC Neurol, 2021, 21(1): 191.
|
14 |
Liu MS, Liao Y, Li GQ. Glomerular filtration rate is associated with hemorrhagic transformation in acute ischemic stroke patients without thrombolytic therapy [J]. Chin Med J (Engl), 2018, 131(14): 1639-1644.
|
15 |
Eun MY, Park JW, Cho BH, et al. Influence of estimated glomerular filtration rate on clinical outcomes in patients with acute ischemic stroke not receiving reperfusion therapies [J]. J Clin Med, 2021, 10(20): 4719.
|
16 |
Tu HT, Campbell BC, Christensen S, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation [J]. Int J Stroke, 2015, 10(4): 534-540.
|
17 |
Chen Y, Zhang Q, You N, et al. [Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke] [J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2020, 32(11): 1340-1345.
|
18 |
熊莉君, 张临洪. 急性脑梗死出血转化危险因素研究 [J]. 中国全科医学, 2014, 17(15): 1707-1709, 1722.
|